These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30250401)

  • 1. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
    An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
    Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.
    Zhang HY; Xing MQ; Guo J; Zhao JC; Chen X; Jiang Z; Zhang H; Dong Q
    Cancer Cell Int; 2019; 19():313. PubMed ID: 31787850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p.
    Kong L; Zhang C
    Cancer Cell Int; 2020; 20():370. PubMed ID: 32774164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.
    Guo J; Chen Z; Jiang H; Yu Z; Peng J; Xie J; Li Z; Wu W; Cheng Z; Xiao K
    Cancer Cell Int; 2019; 19():312. PubMed ID: 31787849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA
    Sun W; Zhang L; Yan R; Yang Y; Meng X
    Onco Targets Ther; 2019; 12():3945-3954. PubMed ID: 31190891
    [No Abstract]   [Full Text] [Related]  

  • 11. Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer.
    Yang J; Ye Z; Mei D; Gu H; Zhang J
    Cancer Manag Res; 2019; 11():4209-4221. PubMed ID: 31118816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway.
    Zhang N; Meng X; Mei L; Zhao C; Chen W
    J Cell Biochem; 2019 Jul; 120(7):11478-11489. PubMed ID: 30838699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
    Wu F; Gao H; Liu K; Gao B; Ren H; Li Z; Liu F
    Onco Targets Ther; 2019; 12():657-667. PubMed ID: 30705594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer.
    You Q; Shi HY; Gong CF; Tian XY; Li S
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6429-6435. PubMed ID: 31378881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
    Zhao Z; Liang S; Sun F
    Front Oncol; 2020; 10():1172. PubMed ID: 32850336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 19. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
    Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
    Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA DLX6-AS1 functions as a competing endogenous RNA for miR-577 to promote malignant development of colorectal cancer.
    Zhou FR; Pan ZP; Shen F; Huang LQ; Cui JH; Cai K; Guo XL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3742-3748. PubMed ID: 31115000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.